AstraZeneca, GSK intensify China ties with Sino Biopharm deals

🇺🇸 BioPharma Dive (US) —
AstraZeneca, GSK intensify China ties with Sino Biopharm deals

AI Summary

U.K. drugmakers AstraZeneca and GSK expanded partnerships with Chinese firm Sino Biopharm amid heightened scrutiny of such deals in the U.S. market.

The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.

Markets Deals Health AstraZeneca GSK China Sino Biopharm pharma deals drugmakers

Read original source →